MMPP
Product Specifications
CAS Number
1895957-18-2
Target
STAT, VEGFR
Related Pathways
Stem Cells, Tyrosine Kinase/Adaptors, JAK/STAT signaling, Angiogenesis
Purity
>99.99%
Bioactivity
MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
Smiles
C(=C/CC1=CC=C(OC)C=C1)\C2=CC(OC)=C(O)C=C2
Molecular Formula
C17H18O3
Molecular Weight
270.32
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2'-Deoxy-3',5'-bis-O-[ (1,1-dimethylethyl) dimethylsilyl]-8-[ (1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl) amino]-6-O- (phenylmethyl) guanosine](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
421089-01 1 mg
2'-Deoxy-3',5'-bis-O-[ (1,1-dimethylethyl) dimethylsilyl]-8-[ (1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl) amino]-6-O- (phenylmethyl) guanosine
Sign In for Pricing
View Details 421089-02 5 mg
2'-Deoxy-3',5'-bis-O-[ (1,1-dimethylethyl) dimethylsilyl]-8-[ (1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl) amino]-6-O- (phenylmethyl) guanosine
Sign In for Pricing
View Details MBS1077885-01 0.02 mg (E-Coli)
Recombinant Bacillus subtilis HTH-type transcriptional activator hxlR (hxlR)
Sign In for Pricing
View Details MBS1077885-02 0.1 mg (E-Coli)
Recombinant Bacillus subtilis HTH-type transcriptional activator hxlR (hxlR)
Sign In for Pricing
View Details MBS1077885-03 0.02 mg (Yeast)
Recombinant Bacillus subtilis HTH-type transcriptional activator hxlR (hxlR)
Sign In for Pricing
View Details MBS1077885-04 0.1 mg (Yeast)
Recombinant Bacillus subtilis HTH-type transcriptional activator hxlR (hxlR)
Sign In for Pricing
View Details